- Home
- NVO vs CRWD Comparison
NVO vs CRWD Comparison
Compare NVO & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | CRWD |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | Denmark | United States |
| Employees | N/A | 11706 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.4B | 232.8B |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NVO | CRWD |
|---|---|---|
| Price | $38.70 | $226.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 53 |
| Target Price | $45.68 | ★ $246.15 |
| AVG Volume (30 Days) | ★ 11.9M | 7.0M |
| Earning Date | 11-04-2026 | 12-01-2026 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | N/A | $24.84 |
| Revenue Next Year | $1.39 | $22.71 |
| P/E Ratio | ★ $13.60 | $8,158.00 |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $35.12 | $174.14 |
| 52 Week High | $64.16 | $786.00 |
Technical Indicators
Market Signals| Indicator | NVO | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 38.40 |
| Support Level | $38.02 | $178.38 |
| Resistance Level | $39.58 | $233.88 |
| Average True Range (ATR) | 0.64 | 9.70 |
| MACD | 0.35 | -4.85 |
| Stochastic Oscillator | 67.40 | 4.42 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.